Diagnosis and management of bronchiolitis
- PMID: 17015575
- DOI: 10.1542/peds.2006-2223
Diagnosis and management of bronchiolitis
Abstract
Bronchiolitis is a disorder most commonly caused in infants by viral lower respiratory tract infection. It is the most common lower respiratory infection in this age group. It is characterized by acute inflammation, edema, and necrosis of epithelial cells lining small airways, increased mucus production, and bronchospasm. The American Academy of Pediatrics convened a committee composed of primary care physicians and specialists in the fields of pulmonology, infectious disease, emergency medicine, epidemiology, and medical informatics. The committee partnered with the Agency for Healthcare Research and Quality and the RTI International-University of North Carolina Evidence-Based Practice Center to develop a comprehensive review of the evidence-based literature related to the diagnosis, management, and prevention of bronchiolitis. The resulting evidence report and other sources of data were used to formulate clinical practice guideline recommendations. This guideline addresses the diagnosis of bronchiolitis as well as various therapeutic interventions including bronchodilators, corticosteroids, antiviral and antibacterial agents, hydration, chest physiotherapy, and oxygen. Recommendations are made for prevention of respiratory syncytial virus infection with palivizumab and the control of nosocomial spread of infection. Decisions were made on the basis of a systematic grading of the quality of evidence and strength of recommendation. The clinical practice guideline underwent comprehensive peer review before it was approved by the American Academy of Pediatrics. This clinical practice guideline is not intended as a sole source of guidance in the management of children with bronchiolitis. Rather, it is intended to assist clinicians in decision-making. It is not intended to replace clinical judgment or establish a protocol for the care of all children with this condition. These recommendations may not provide the only appropriate approach to the management of children with bronchiolitis.
Comment in
-
Oxygen therapy for bronchiolitis.Pediatrics. 2007 Mar;119(3):611. doi: 10.1542/peds.2006-3002. Pediatrics. 2007. PMID: 17332214 No abstract available.
-
High-dose systemic corticosteroids may be effective early in the course of bronchiolitis.Pediatrics. 2007 Apr;119(4):864-5; discussion 865-6. doi: 10.1542/peds.2006-2888. Pediatrics. 2007. PMID: 17403865 Clinical Trial. No abstract available.
-
The importance of disclaimers: distinction between optimal care and standard of care.Pediatrics. 2007 Aug;120(2):453-5; author reply 455. doi: 10.1542/peds.2007-0951. Pediatrics. 2007. PMID: 17671079 No abstract available.
-
Health care epidemiology perspective on the October 2006 recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis.Pediatrics. 2007 Oct;120(4):890-2. doi: 10.1542/peds.2007-1305. Pediatrics. 2007. PMID: 17908774 No abstract available.
Similar articles
-
Clinical practice guideline: Otitis media with effusion.Otolaryngol Head Neck Surg. 2004 May;130(5 Suppl):S95-118. doi: 10.1016/j.otohns.2004.02.002. Otolaryngol Head Neck Surg. 2004. PMID: 15138413
-
Bronchiolitis: from empiricism to scientific evidence.Minerva Pediatr. 2009 Apr;61(2):217-25. Minerva Pediatr. 2009. PMID: 19322125 Review.
-
[Management of bronchiolitis in infants].Soins Pediatr Pueric. 2001 Oct;(202):16-21. Soins Pediatr Pueric. 2001. PMID: 11949584 Review. French. No abstract available.
-
Management of bronchiolitis: current practices in Ireland.Ir Med J. 2002 Jun;95(6):167-9. Ir Med J. 2002. PMID: 12171262
-
Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction.Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S83-7; discussion S87-8. doi: 10.1097/01.inf.0000053890.66801.97. Pediatr Infect Dis J. 2003. PMID: 12671457 Review.
Cited by
-
Clinical Profile and Outcome of Bronchiolitis in Children With 1-24 Months of Age.Cureus. 2024 Sep 18;16(9):e69640. doi: 10.7759/cureus.69640. eCollection 2024 Sep. Cureus. 2024. PMID: 39429418 Free PMC article.
-
Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case-control study.Lancet Reg Health Eur. 2024 Jul 23;44:101007. doi: 10.1016/j.lanepe.2024.101007. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39139197 Free PMC article.
-
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers.Infect Dis Ther. 2024 Sep;13(9):2053-2070. doi: 10.1007/s40121-024-01024-y. Epub 2024 Aug 4. Infect Dis Ther. 2024. PMID: 39097549 Free PMC article.
-
Evaluation of the Clinical, Laboratory and Radiology Findings and Treatment Methods of Children with Acute Bronchiolitis: Experience of a Tertiary Center.Sisli Etfal Hastan Tip Bul. 2024 Apr 5;58(1):102-108. doi: 10.14744/SEMB.2023.95605. eCollection 2024. Sisli Etfal Hastan Tip Bul. 2024. PMID: 38808052 Free PMC article.
-
Emergency Department Initiative to Decrease High-flow Nasal Cannula Use for Admitted Patients with Bronchiolitis.Pediatr Qual Saf. 2024 May 9;9(3):e728. doi: 10.1097/pq9.0000000000000728. eCollection 2024 May-Jun. Pediatr Qual Saf. 2024. PMID: 38751897 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
